NFKB1 and diabetes mellitus: Recently, NF-κB was evaluated in the liver of dogs with experimentally induced type 1 diabetes mellitus, showing a reduction in its activity and in serum liver enzymes in dogs treated with N-acetyl-cysteine and insulin compared to untreated dogs [32].